IP Library Granted Patent US 7,306,809
Granted Patent B2
US 7,306,809 · App. 10/243,060 · Granted Dec 11, 2007

Optically activated particles for use in cosmetic compositions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,306,809
App. No.
10/243,060
Granted
Dec 11, 2007
Kind
B2
Abstract

Optically activated particles for use in cosmetic and pharmaceutical compositions are disclosed. The optically activated particles include a solid substrate having a fluorescent compound fixed thereto, and coated or encapsulated with a transparent or translucent coating of crosslinked polyvinyl alcohol. The optically activated particles absorb light at a UV wavelength and emit visible light at longer wavelengths, and are able to both absorb and scatter light in a diffuse manner in order to reduce the visual perception of skin imperfections, including cellulite, wrinkles, shadows, skin discolorations, blotchiness, and mild scars.

Claims (23)

1. An optically activated particle comprising

(a) a solid substrate;

(b) a fluorescent compound fixed on the solid substrate; and

(c) a crosslinked polyvinyl alcohol shell covering the solid substrate and fluorescent compound.

2. The particle of claim 1 wherein the solid substrate comprises a synthetic polymeric substrate, a natural polymeric material, an insoluble salt, a mineral, or a mixture thereof.

3. The particle of claim 2 wherein the solid substrate comprises a synthetic polymeric substrate selected from the group consisting of a polyamide, a polyacetate, a polyester, a polyacrylic, a polyethylene, a polypropylene, a rayon, a polyvinyl chloride, and mixtures thereof.

4. The particle of claim 2 wherein the solid substrate comprises a natural polymeric material selected from the group consisting of cellulose, regenerated cellulose, starch, a microcrystalline cellulose, and mixtures thereof.

5. The particle of claim 1 wherein the solid substrate has a median particle size of about 0.1 to about 50 microns in diameter.

6. The particle of claim 1 wherein the solid substrate has a median particle size of about 2 to about 15 microns in diameter.

7. The particle of claim 1 wherein the substrate, solid or hollow, is a sphere, a cube, a cylinder, a tetrahedroid, a rhomboid, a plate, or is irregularly shaped.

8. The particle of claim 1 wherein the substrate is a solvent swollen substrate, said solvent comprising an alcohol, diol, polyol, or mixtures thereof.

9. The particle of claim 1 wherein the fluorescent compound is present in an amount of about 0.01% to about 1%, by weight of the solid substrate.

10. The particle of claim 1 wherein the fluorescent compound is present in an amount of about 0.05% to about 0.5%, by weight of the solid substrate.

11. The particle of claim 1 wherein the fluorescent compound is selected from the group consisting of a 4,4′-diaminostilbene-2,2′-disulfonic acid, a 2-(stilben-4-yl)naphthotriazole, a 2-(4-phenylstilben-4-yl)benzoxazole, a bis-(azol-2-yl)stilbene, a 1,4-bis(styryl)benzene, a 4,4′-bis(styryl)biphenyl, a 1,3-diphenyl-2-pyrazoline, a bis(benzooxazol-2-yl), a bis(benzimidazol-2-yl), a 2-(benzofuran-2-yl)benzimidazole, a coumarin, a carbostyril, a naphthalimide, a quaternized pyridotriazole, a pyrene compound, a 3,7-diaminodibenzothiophene-2,8-disulfonic acid-5,5-dioxide, and mixtures thereof.

12. The particle of claim 1 wherein the crosslinked polyvinyl alcohol is about 70% to 100% hydrolyzed.

13. The particle of claim 1 wherein the crosslinked polyvinyl alcohol is present in an amount of about 0.01% to about 25%, by weight of the particle.

14. The particle of claim 1 wherein the crosslinked polyvinyl alcohol is crosslinked by a multifunctional aldehyde.

15. A topically applied composition comprising optically activated particles of claim 1 .

16. The composition of claim 15 wherein the composition is a liquid comprising about 0.5% to about 20% of the optically activated particles, by weight of the composition.

17. The composition of claim 15 wherein the composition is a solid comprising about 0.5% to about 50% of the optically activated particles, by weight of the composition.

18. The composition of claim 15 selected from the group consisting of a skin lotion, a cream, a hair shampoo, a body rinse, a bath gel, a skin-cleansing agent, a hair conditioner, a skin coloring composition, a hair colorant, a foundation liquid, a foundation powder, a topical skin treatment.

19. A method of reducing a visual perception of skin imperfections comprising topically applying optically activated particles of claim 1 to human skin.

20. The method of claim 19 wherein the skin imperfection is selected from the group consisting of wrinkles, cellulite, skin discoloration, shadows, pores, scars, varicose veins, follicles, and blotchiness.

Assignments (12)
TERMINATION AND RELEASE OF FIRST LIEN SECURITY INTEREST IN PATENTS RECORDED AT REEL 044700, FRAME 0728 Recorded Aug 29, 2025
From: MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT
To: VANTAGE SPECIALTIES, INC.; VANTAGE SPECIALTY INGREDIENTS, INC.
Reel/Frame 072759/0388 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN SECOND LIEN PATENT SECURITY AGREEMENT RECORDED AT REEL 044700, FRAME 0582 Recorded Mar 14, 2023
From: MORGAN STANLEY SENIOR FUNDING, INC. AS COLLATERAL AGENT
To: VANTAGE SPECIALTIES, INC.; VANTAGE SPECIALITY INGREDIENTS, INC.
Reel/Frame 063084/0479 →
RELEASE OF SECURITY INTEREST Recorded Dec 11, 2017
From: FIFTH THIRD BANK
To: VANTAGE SPECIALTIES, INC.; VANTAGE SPECIALTY INGREDIENTS, INC. (F/K/A LIPO CHEMICALS, INC.)
Reel/Frame 044356/0864 →
SECOND LIEN PATENT SECURITY AGREEMENT Recorded Dec 5, 2017
From: VANTAGE SPECIALTIES, INC.; VANTAGE SPECIALTY INGREDIENTS, INC.
To: MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT
Reel/Frame 044700/0582 →
FIRST LIEN PATENT SECURITY AGREEMENT Recorded Dec 5, 2017
From: VANTAGE SPECIALTIES, INC.; VANTAGE SPECIALTY INGREDIENTS, INC.
To: MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT
Reel/Frame 044700/0728 →
RELEASE OF SECURITY INTEREST Recorded Oct 27, 2017
From: ROYAL BANK OF CANADA, AS ADMINISTRATIVE AGENT
To: VANTAGE SPECIALTIES, INC.; VANTAGE OLEOCHEMICALS, INC.; VANTAGE SPECIALTY CHEMICALS INC.; M.E.C. NEXT GENERATION, LLC; ESTHER HOLDING CORPORATION,; MANYA MANAGEMENT, LLC,; MANYA HOLDINGS, LP,; VANTAGE SPECIALTY INGREDIENTS, INC.; DESERT WHALE JOJOBA COMPANY, INC; MALLET AND COMPANY INC.
Reel/Frame 043967/0730 →
RELEASE OF SECURITY INTEREST Recorded Oct 26, 2017
From: ROYAL BANK OF CANADA AS ADMINISTRATIVE AGENT
To: VANTAGE SPECIALTIES, INC.; LIPO CHEMICALS, INC.
Reel/Frame 043962/0043 →
CHANGE OF NAME Recorded Oct 23, 2017
From: LIPO CHEMICALS, INC.
To: VANTAGE SPECIALTY INGREDIENTS, INC.
Reel/Frame 044259/0543 →
SECURITY INTEREST Recorded Aug 5, 2016
From: VANTAGE SPECIALTIES, INC.; VANTAGE OLEOCHEMICALS, INC.; VANTAGE SPECIALTY CHEMICALS, INC.; M.E.C. NEXT GENERATION, LLC; ESTHER HOLDING CORPORATION; MANYA MANAGEMENT, LLC; MANYA HOLDINGS, LP; VANTAGE SPECIALTY INGREDIENTS, INC.; DESERT WHALE JOJOBA COMPANY, INC.; MALLET AND COMPANY, INC.
To: ROYAL BANK OF CANADA
Reel/Frame 039352/0674 →
SECURITY AGREEMENT Recorded Feb 24, 2012
From: VANTAGE SPECIALTIES, INC.; LIPO CHEMICALS, INC.
To: ROYAL BANK OF CANADA
Reel/Frame 027756/0759 →
RELEASE OF SECURITY INTEREST Recorded Jul 19, 2010
From: PNC BANK, NATIONAL ASSOCIATION, AS AGENT
To: LIPO CHEMICALS, INC.
Reel/Frame 024697/0770 →
SECURITY AGREEMENT Recorded Jul 15, 2010
From: LIPO CHEMICALS, INC.
To: FIFTH THIRD BANK, AS ADMINISTRATIVE AGENT
Reel/Frame 024686/0742 →